The Ark boss just made a massive AI bet.

On the buying side, ARK continues to show interest in the artificial intelligence space. The fund acquired 7,737 shares of Tempus AI Inc (NASDAQ:TEM) across its ARKK and ARKG ETFs, totaling $505,380.

ARK Invest sold $5M Beam Therapeutics and bought WeRide, Tempus AI stock Jan 22. See Cathie Wood's complete trading report and portfolio changes.

On the selling side, ARK offloaded 135,193 shares of Beam Therapeutics Inc (NASDAQ:BEAM), with a total dollar value of $4,186,927. This sale was distributed between ARKK and ARKG ETFs, suggesting a ...

Cathie Wood's ARK sold $2.78M Twist Bioscience, bought Tempus AI & WeRide Jan 26. Full breakdown of ARK Invest's latest AI ...

Cathie Wood’s ARK Invest repositions toward long-term innovation themes like advanced air mobility, autonomous transport, and gene editing during the last week, while reducing exposure to more mature ...

Cathie Wood’s ARK Invest (ARKK) deepened investment in AI chipmakers, gene-editing companies, and autonomous-driving ...

Cathie Wood is sticking to her playbook. In her latest weekly update, ARK Invest leaned further into long-term bets on AI ...

Should investors be wary of AMD's cheaper data center GPUs?

Cathie Wood's ARK Invest adjusted its portfolio last week, showing renewed focus on AI chipmakers, gene-editing firms, and ...